MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 78 filers reported holding MERSANA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $399,227 | -89.7% | 314,352 | -73.4% | 0.00% | -100.0% |
Q2 2023 | $3,894,429 | +108.1% | 1,183,717 | +160.0% | 0.00% | – |
Q1 2023 | $1,871,225 | +699.3% | 455,286 | +1039.6% | 0.00% | – |
Q4 2022 | $234,119 | -66.2% | 39,952 | -61.0% | 0.00% | – |
Q3 2022 | $692,000 | +686.4% | 102,415 | +436.4% | 0.00% | – |
Q2 2022 | $88,000 | -87.3% | 19,093 | -89.0% | 0.00% | – |
Q1 2022 | $693,000 | -54.3% | 173,786 | -28.8% | 0.00% | – |
Q4 2021 | $1,518,000 | +36.8% | 243,914 | +107.2% | 0.00% | – |
Q3 2021 | $1,110,000 | -60.3% | 117,741 | -42.8% | 0.00% | – |
Q2 2021 | $2,798,000 | -57.5% | 206,002 | -49.3% | 0.00% | – |
Q1 2021 | $6,576,000 | +167.1% | 406,379 | +339.3% | 0.00% | – |
Q4 2020 | $2,462,000 | -42.6% | 92,514 | -59.8% | 0.00% | – |
Q3 2020 | $4,289,000 | +196.2% | 230,353 | +272.4% | 0.00% | – |
Q2 2020 | $1,448,000 | +788.3% | 61,864 | +121.2% | 0.00% | – |
Q1 2020 | $163,000 | +526.9% | 27,970 | +70.7% | 0.00% | – |
Q3 2019 | $26,000 | -94.3% | 16,381 | -85.4% | 0.00% | – |
Q2 2019 | $455,000 | – | 112,077 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |